SCHEMBL17850641

SCHEMBL17850641

C=Cc1[nH]cnc1/C=C/CCC

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17850627 0.90 ALDH1A1 (0.32) PDE4AADORA2AADORA2BPDE4BPDE4C
SCHEMBL18731796 0.86 CDK1 (0.31)
SCHEMBL22016102 0.78
SCHEMBL7033242 0.75
SCHEMBL17850645 0.74
SCHEMBL22351867 0.74 HRH2 (0.31)
SCHEMBL24044931 0.71 CDK1 (0.31)
SCHEMBL16247887 0.67
SCHEMBL19737638 0.67
SCHEMBL17850638 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2714036-B1 SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS ACHILLION PHARMACEUTICALS INC (US) 2016-06-22 EP disclosed